Stock ABT ABBOTT LABORATORIES
Add to a list
To use this feature you must be a member
Log inSign up

News Abbott Laboratories

Equities

ABT

US0028241000

Real-time Estimate Cboe BZX
Other stock markets
 09:57:37 2024-06-10 am EDT 		5-day change 1st Jan Change
108.6 USD +0.93% Intraday chart for Abbott Laboratories +5.02% -1.85%
02:33pm Abbott Laboratories Says US FDA Approved 2 Over-The-Counter Continuous Glucose Monitoring Wearable Systems MT
02:08pm US FDA clears Abbott's continuous glucose monitors for over-the-counter use RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Abbott Laboratories Says US FDA Approved 2 Over-The-Counter Continuous Glucose Monitoring Wearable Systems
MT
US FDA clears Abbott's continuous glucose monitors for over-the-counter use
RE
Abbott Laboratories : Receives CE Mark for AVEIR™ DR, the World's First Dual Chamber Leadless Pacemaker System
PU
Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients
PR
U.S. FDA set to reorganize its food division starting October
RE
Redburn Adjusts Price Target on Abbott Laboratories to $113 From $115
MT
Medtronic beats quarterly profit estimates on medical devices strength
RE
Citigroup Adjusts Price Target on Abbott Laboratories to $119 From $128, Keeps Buy Rating
MT
Abbott Laboratories Recalling HeartMate 3 Left Ventricular Assist System Implant Kit
MT
Understanding Product-By-Process Claims In Patent Law
AQ
Drugmaker Abbott India posts Q4 profit rise on higher sales
RE
Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing
MT
Abbott Laboratories Announces Retirement of Robert E. Funck, Jr as Executive Vice President, Finance, Effective July 1, 2024
CI
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
AQ
Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee
MT
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
PR
Dexcom's profit beats estimates on strong glucose monitor demand
RE
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength
RE
Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126
MT
Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABT Stock
  4. News Abbott Laboratories